glp 1 amgen GLP-1 drugs, like Ozempic and Wegovy, linked to low blood pressure risk: Northwestern study Amgen and Pfizer's Monthly GLP-1s
Description
PMID: 37288303
Starting a GLP-1 for weight loss
Are they even remotely realistic?
The signaling-specific inhibitor AEF0117 selectively inhibits CB1 activation by THC and reduces self-administration and subjective effects of cannabis in clinical trials, making it a potential treatment for cannabis use disorder.
no FDA-approved retail pricing exists as of April 2026
